Sharon Benzeno

Sharon Benzeno

Corporate Officer/Principal at ADAPTIVE BIOTECHNOLOGIES CORPORATION

Net worth: 1 M $ as of 2024-03-30

50 year
Consumer Services
Health Technology
Technology Services

Profile

Sharon Benzeno is currently the Chief Commercial Officer-Immune Medicine at Adaptive Biotechnologies Corp.
Prior to this, she held the position of Senior Director at Elsevier, Inc. from 2013 to 2014.
She also worked as a Senior Scientific Manager at AstraZeneca PLC from 2005 to 2011 and as a Senior Manager at Capgemini SE from 2011 to 2013.
Dr. Benzeno completed her undergraduate degree at New York University, obtained an MBA from The Leonard N Stern School of Business, and earned a doctorate from New York University School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-04 327,415 ( 0.23% ) 1 M $ 2024-03-30

Sharon Benzeno active positions

CompaniesPositionStart
ADAPTIVE BIOTECHNOLOGIES CORPORATION Corporate Officer/Principal 2018-01-31
All active positions of Sharon Benzeno

Former positions of Sharon Benzeno

CompaniesPositionEnd
Director/Board Member 2014-08-31
CAPGEMINI SE Corporate Officer/Principal 2013-11-30
ASTRAZENECA PLC Corporate Officer/Principal 2011-04-30
See the detail of Sharon Benzeno's experience

Training of Sharon Benzeno

New York University Undergraduate Degree
The Leonard N Stern School of Business Masters Business Admin
New York University School of Medicine Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sharon Benzeno's experience

Connections

100 +

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
ASTRAZENECA PLC

Health Technology

CAPGEMINI SE

Technology Services

ADAPTIVE BIOTECHNOLOGIES CORPORATION

Health Technology

Private companies1

Consumer Services

See company connections
  1. Stock Market
  2. Insiders
  3. Sharon Benzeno
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW